LYSOVANT SCIENCES HOLDINGS LIMITED
Company number 11657920 · Monitor this company
Overview
- Company type
- Private Limited Company
- Incorporated
- 2018-11-05
- Dissolved
- 2025-03-18
- Registered office
- 7th Floor 50 Broadway, London, United Kingdom, SW1H 0DB
- Postcode
- SW1H 0DB
- Capital
- 20,560 USD
- Accounts category
- Small
Accounts
- Last made up to
- 2023-03-31
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2024-11-04
Nature of business (SIC)
- 64209 Activities of other holding companies not elsewhere classified
Officers 4 current · 2 resigned
Emma Carys PRICE
Director
Caterina Musgrave JUER
Director
MS EVIA MARY SOUSSI
Director
VISTRA COSEC LIMITED
Corporate Secretary · corporate
Group structure
Controlled by Roivant Sciences Ltd. (00048931) — since 2021-10-01
From persons-with-significant-control filings on the public register.
Contact details
- Website
- lysovant.com
Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology.
Previous company names
| Name | Date changed |
|---|---|
| PHARMAVANT 1 HOLDINGS LTD. | 2019-02-06 |
The class of 2018
61%
of the 7,931 companies in this sector incorporated in 2018 are still active today; 36% have since been dissolved.
A fact about the year, not a forecast for this company.